Duncan Bucknell
Strategic Intellectual Property
The global dispute between Amgen and Sanofi over patent claims to Amgen’s drug Repatha® (evoloumab) saw another chapter close on 24 April. In this installment, the Australian Federal Court dismissed Sanofi’s...
Trending in intellectual property at the moment: Apple ordered to pay US $502m plus compound interest to non practicing entity Optis in FRAND patent infringement appeal to UK Court of Appeal....
Here’s a quick update on recent and important IP issues. You still need to clear the way in UK pharma patent cases. Loss of first mover advantage still holds great weight....
A self represented litigant had applied for a trade mark for “BYRON BAY BEACHFRONT APARTMENTS” which was rejected. He appealed to the Federal Court, did not fully understand the process and...
Additional Damages are fairly unusual, but can be awarded in IP Litigation based on the flagrancy of infringement, the conduct of the defendant and other matters. In a Design Infringement case...
In the early stages of patent infringement proceedings, each of the respondents (defendants) argued that Scidera had not put its case sufficiently clearly to the court in its pleadings (Statement of...
How to make good IP decisions when there’s no time to spare, in a complex and rapidly evolving world? Can you balance multiple perspectives and factors in the heart of the...
At what point in the future will you be able to challenge a competitors patents for lack of inventorship because they were AI generated not human generated? Is it still protected...
An act of deception has won many a military battle – from Sun Tzu to the Trojan Horse, from Alexander the Great, Hannibal or Napolean to the Spaniards defeating the overwhelmingly...
Strategy without analysis is like turning up to play a sporting match when you don’t know what sport you’re playing, what equipment to bring, the rules, who your opponent is or...
You must be logged in to post a comment.